<p>The invention relates generally to the use of N-substituted dopamine derivatives for the treatment of diseases and disorders that involve abnormal lipid peroxidation. This method comprises the administration of a pharmaceutically effective amount of Nacetyldopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating an animal or human suffering abnormal lipid peroxidation. The N-acetyldopamine derivative or N-alkyldopamine derivatives may be administered alone or in combination with N-acetylserotonin (NAS) to inhibit lipid peroxidation.</p>
申请公布号
WO2006014507(A2)
申请公布日期
2006.02.09
申请号
WO2005US24023
申请日期
2005.07.07
申请人
CARITAS ST. ELIZABETH HOSPITAL OF BOSTON, INC.;OXENKRUG, GREGORY;REQUINTINA, PURA, J.